
Loading, please wait...

Loading, please wait...

This meta-analysis of 41 studies found a 46.7% global prevalence of painful diabetic peripheral neuropathy (PDPN) in DPN patients. The results indicated that PDPN prevalence varied by diagnostic method and diabetes duration. Risk factors included older age, female gender, BMI ≥30 kg/m², longer diabetes duration, and nephropathy. Targeted screening and standardized diagnostic tools are crucial for effective PDPN management.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This meta-analysis of 41 studies found a 46.7% global prevalence of painful diabetic peripheral neuropathy (PDPN) in DPN patients. The results indicated that PDPN prevalence varied by diagnostic method and diabetes duration. Risk factors included older age, female gender, BMI ≥30 kg/m², longer diabetes duration, and nephropathy. Targeted screening and standardized diagnostic tools are crucial for effective PDPN management.
2 months ago

A recent study demonstrates that spinal oxygen sensors do not require mitochondrial electron transport to trigger sympathetic excitation during acute hypoxia, revealing new insights into how mitochondrial oxidative stress modulates autonomic tone in cardiovascular and neurological diseases.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today